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Potential role of PFOB enhanced sonography of the kidney. I. Detection
of renal function and acute tubular necrosis. Perfluorooctylbromide
(PFOB) enhances the echogenicity of perfused tissues on sonography.
Since PFOB is not filtered and is limited to the intravascular space, the
particles are concentrated in the vasa rectae as they travel across the
osmotic gradient. Because sonography has been unable to detect renal
function, we aimed to determine whether sonography when aided by
PFOB could detect and distinguish the normal from the abnormal
osmotic gradient. The sonographer, unaware of rabbit assignment,
imaged both kidneys in 17 rabbits before and 24 hours after the
temporary occlusion of one of the renal arteries and then again after the
infusion of up to 5 mi/kg of PFOB (N = 10) or saline (N = 7). Two
normal rabbits were imaged before and after PFOB infusion and then
again after iv. furosemide. Without PFOB, the normal and impaired
kidneys were indistinguishable. The echogenicity of the medulla which
was darker than cortex in normal kidneys became brighter than cortex
after PFOB (increased by 117% 10%; P < 0.01). PFOB, which was
visible in the renal medulla on real-time sonography, produced an
echogenic gradient that increased in brightness towards the papillary
tip. Because the medulla of kidneys with ATN mildly increased in
brightness after PFOB (increased by 40% 7.8%; P < 0.01), and
because the echogenic gradient produced by PFOB was reversed
(decreased in brightness towards the papillary tip), ATN kidneys were
distinguished from normal kidneys in all 10 rabbits after 2.5 mI/kg
PFOB. Medullary echogenicity produced by PFOB in normal kidneys
was lost after furosemide. Our results showed that sonography, when
aided by a blood pool contrast agent, can for the first time reliably
distinguish a normally functioning kidney from a kidney with an
impaired osmotic gradient.
Sonography has been useful in detecting anatomic abnormal-
ities in the kidney such as hydronephrosis, complex and solid
masses, and benign simple renal cysts just to name a few [11.
However, aside from the Doppler assessment of blood velocity
through the renal arterial tree, it is unable to detect changes in
renal function, even those produced by acute renal tubular
necrosis (ATN) [2—51.
We noted that perfluorooctylbromide (PFOB) (ImagentR BP,
Alliance Pharmaceutical Corp, San Diego, California, USA), a
radiopaque fluorocarbon that is limited to the intravascular
space and serves as a blood pooi contrast agent for computed
tomography, causes greater enhancement of the renal medulla
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than in the cortex on CT [61. Using a canine model, we showed
that medullary enhancement was due to the concentration of
PFOB in the vasa rectae which reflected the osmotic gradient
[7]. We have also demonstrated that PFOB is an effective
sonographic contrast agent that enhances Doppler signals and
perfused tissues immediately after its intravenous administra-
tion [8—101.
The intent of this study was to determine if PFOB causes
increased echogenicity of the renal medulla relative to cortex in
normally functioning kidneys. Since ATN and furosemide are
known to destroy the osmotic gradient [11], we also aimed to
explore whether PFOB enhanced sonography could detect
changes in medullary echogenicity to reflect the altered osmotic
gradient. Finally, we aimed to determine if an alteration in
medullary echogenicity caused by the destruction of the os-
motic gradient is sufficient to allow the distinction of kidneys
with normal from those with abnormal concentrating ability.
Methods
Experimental protocol
The protocol is shown in Figure 1. Seventeen New Zealand
white rabbits weighing 2 to 3 kg were studied. Unilateral
ischemic acute tubular necrosis was surgically induced by using
the model described by Lavelle et al [12] with the addition of
i.v. heparin (250 U). Following anesthesia, and through a
midline incision, one of the renal arteries was occluded with an
inflatable hydraulic occluder for 1.5 to 2.0 hours. The incision
was closed, the animals were given 100,000 units procaine
penicillin intramuscularly, and allowed to recover for 24 hours.
At the completion of the experiment, the animals were sacri-
ficed, both kidneys removed, and a 2 mm midplane transaxial
slice was taken from each kidney for H&E staining and micros-
copy.
Sonography was performed with an Acuson unit (Melpitas,
California, USA) equipped with a 5 MHz L-558 transducer. All
seventeen rabbits had both kidneys imaged with gray scale
real-time sonography. Two representative still frames of each
kidney in the coronal plane were recorded on film and also on a
broadcast quality 3/4" video tape. All rabbits were scanned
before and at 24 hours after ATN induction by a sonographer
blinded to the side with ATN. Following the second scan, 10
rabbits received incremental doses of 1 mi/kg, 1.5 mI/kg and 2.5
mi/kg, for a total dose of 5 ml (5 g)/kg PFOB (Alliance). The
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remaining seven rabbits received a single dose of 5 mi/kg saline
and were rescanned immediately after the entire volume was
infused. Blinding the sonographer to drug was futile since the
effect of PFOB on tissues and vessels was obvious.
Since the hypothesis that sonography would detect ATN
after PFOB is based upon the fact that ATN destroys the
osmotic gradient, two normal rabbits were infused with 2.5
mi/kg PFOB and imaged before and after 50 mg furosemide
given i.v.
Data recorded: Qualitative
The sonographer, while observing the real-time study, was
asked to pick out the normal kidney before contrast adminis-
tration and also after the cumulative doses of 1.0, 2.5, and 5.0
mi/kg PFOB or 5.0 ml/kg saline. If the sonographer could not
recognize the normal from the ATN kidney, no choice was
made. The PFOB dose level at which the sonographer could
confidently distinguish the normal from the impaired kidney
was recorded.
An independent reviewer, blinded to the contrast used and
the side with ATN, evaluated the still images recorded on film,
The reviewer was asked to identify the normal kidney by
evaluating medullary echogenicity relative to cortex. The dose
level at which the reviewer could confidently distinguish the
normal from the abnormal kidney was recorded.
The sonographer and the reviewer were then told which was
the normal kidney. They independently reviewed the films to
determine if in retrospect they could detect a change induced by
ATN. They compared the before and after ATN images of each
kidney and the images of the normal and impaired kidneys
within each rabbit prior to contrast administration.
Data recorded: Quantitative
The images of each kidney recorded on video tape were
digitized and analyzed quantitatively to calculate the image
contrast between the medulla and cortex, which was termed
corticomedullary contrast. Digitization was done using an IBM
PC-AT equipped with a 10 MHz PCI A/D converter (Chorus
Data Systems) capable of digitizing images at 512 x 512 pixels
by 256 gray-levels. The operator, blinded to the side with ATN,
drew two regions of interest, one over the cortex and the other
over the medulla near the tip of the papilla at points equidistant
from the face of the ultrasound transducer. The computer then
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Fig. 1. Flow chart detailing the experimental protocol.
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other values were normalized to the control value and the
percent change calculated as: [100 x (Contrast — Contrastcontroj)/
Contrasteontroji. The mean and standard error of the mean of the
percent change in corticomedullary contrast of the normal and
impaired kidneys for the PFOB and saline groups were calcu-
lated for each time point. The percent change was deemed
significant if the P value calculated using the paired t-test was
less than 0.05. When comparing the corticomedullary contrast
of the normal to the impaired kidney for significance, the
unpaired t-test was used.
Results
Histology
ATN kidneys in both groups, showed tubular cell swelling,
tubular casts, and normal glomeruli. Spotty cortical necrosis
(glomerular and vascular damage) was observed in few rabbits.
The contralateral kidneys were histologically normal in all
rabbits. No histologic difference was evident between rabbits
given saline and those given PFOB.
Effect of ATN on corticomedullary contrast
Fig. 2. Quantitative analysis of histogram data to calculate cortico-
medullary contrast. A. Percentile histogram calculated by dividing the
number of pixels per gray level by the total number of pixels in the
region of interest. Symbols are: (—) cortex; (---) medulla. B. Integral of
histograms in 1A show an ever increasing curve from I to 100 as a
function of gray level. "Corticomedullary contrast" was calculated as
the area between the two curves (shaded area). Note that since the
medulla is less echogenic than cortex, its curve is to the left of the
cortex curve.
derived a histogram (* of pixels at each gray-level) for each
region.
All histograms were normalized to obtain a percentile histo-
gram by dividing the number of pixels at each gray level by the
total number of pixels contained in the region of interest (Fig.
2A). The integral of the percentile histogram was then calcu-
lated by assigning to each gray level all pixels contained at and
below that gray level. The integral curve was therefore an ever
increasing number from 1 to 100 (Fig. 2B). The corticomedul-
lary contrast was calculated as the area between the integral
curves of the cortex and medulla (Fig. 2B). The final contrast
value at each time point was the average value of the pair of
images obtained of each kidney. There were five values for the
rabbits given PFOB (pre- and 24 hours post-ATN induction and
post-cumulative doses of 1, 2.5, and 5 mI/kg PFOB) and three
values for rabbits given saline (pre- and 24 hours post-ATN
induction and post-S mi/kg saline).
The control corticomedullary contrast value against which all
other values were compared was the contrast value obtained 24
hours after ATN induction before contrast administration. All
The sonographer and the reviewer when blinded to side that
was normal were unable to prospectively distinguish the normal
from the ATN kidney in any of the 17 animals. However, when
told which was the normal kidney, they were able to observe
that the medulla of the kidney with ATN lost echogenicity and
the medulla of the normal kidney gained echogenicity relative to
the cortex. The normal kidney in each rabbit had more echoes
within the medulla than the impaired kidney in 8 of the 17
rabbits. The difference was moderate in three and mild in five.
The greater number of echoes in the medulla of the normal
kidney was also reflected quantitatively. The corticomedullary
contrast between the normal and the impaired kidney was
significant to P < 0.01. When comparing the percent change in
contrast of each kidney before and after ATN was induced, the
ATN kidneys gained 12.3 5.8% (P < 0.05) (medulla became
less echogenic than cortex) and the normal kidneys lost 32.9
9.9% (P < 0.01) (medulla gained echogenicity relative to
cortex).
Effect of PFOB on corticomedullary contrast
The sonographer and the reviewer were unable to recognize
the normal kidney in any of the seven rabbits given S mi/kg
saline (Fig. 3). They were able to correctly do so in all 10 rabbits
given PFOB. PFOB produced significant echogenic enhance-
ment of the medulla in normal kidneys (Fig. 4). In fact the
normal medulla, which is typically less bright than cortex,
became brighter than cortex after 5 mI/kg PFOB. In contrast,
PFOB had little effect on medullary echogenicity in the ATN
kidney's (Fig. 5). The difference in the enhancement pattern of
the medulla in the normal versus ATN kidneys allowed the
sonographer viewing the real-time study and the reviewer
viewing the still images to recognize the normal kidney in 8 of
10 and 7 of 10 rabbits, respectively, after 1 mI/kg of PFOB was
given. They both recognized the normal kidney in all remaining
rabbits after the cumulative dose of 2.5 mi/kg PFOB. The
difference in medullary enhancement between the normal and
the impaired kidney increased further after S ml/kg.
A
6
5
4
3
x
0
0 2
0
0 10 20 30 40 50 60 70 80
Gray evei
B
100
Medulla
0 10 20 30 40 50 60 70 80
Gray level
80
Ca
60 N
Cortex
-—— ——fl]jQ 141 4fl. - -c
-
1
a- S
————a—
— —
—..
-
- —... — -' •_
— — —
-1
I — •—_ ——
I_
_c—-_ -
-_ _a
736 Muazing et a!: Sonography to detect ATN
Fig. 3. Effect of 5 mi/kg saline on corticomedullary contrast. A. Kidney with acute tubular necrosis obtained after saline infusion shows a dark
medulla (M) and an echogenic cortex (C) which was indistinguishable from the pre-injection image (not shown). B. The normal contralateral kidney
to the kidney shown in 2A also obtained after saline infusion is indistinguishable from the ATN kidney.
Fig. 4. Effect of perfluorooctylbromide (PFOB) on corticomedullary contrast of a normal kidney. A. Image obtained after ATN was induced in
the contralateral kidney prior to PFOB infusion, Note that medulla (M) is hypoechoic relative to cortex (C) with few visible echoes (open arrows).
B. Same kidney as in 3A imaged after 1 mllkg PFOB was infused. Note the increase in medullary echoes and the improved visibility of the
corticomedullary junction (arrows). C. After 2.5 mI/kg PFOB was infused, there is further increase in medullary echoes with a distinctive echogenic
focus at the papillary tip (arrow) where the osmotic gradient is greatest. D. After 5 mI/kg PFOB was infused, the medulla became more echogenic
than cortex. The hypoechoic line at the corticomedullary junction is still visible (arrows).
Fig. 5. Effect of perfluorooctylbromide (PFOB) on corticomedullary
contrast of the kidney with acute tubular necrosis (A TN) in the same
rabbit shown in Figure 3. A. Image obtained after ATN was induced but
prior to PFOB infusion. Note that medulla (M) is hypoechoic relative to
cortex (C) with absent medullary echoes. B. After 2.5 mI/kg PFOB was
infused, medullary echoes remain absent and the corticomedullary
junction remains indistinct in contrast to the normal kidney shown in
Fig. 3C. C. After 5 mI/kg PFOB was infused, there is an increase in
medullary echoes (arrows), however, medulla remains hypoechoic
relative to cortex.
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With real-time sonography of the normal kidney after PFOB
was given, the sonographer observed medullary echoes that
traveled slowly from the corticomedullary junction to the apex
of the papilia and back again in a swirling pattern. This
observation, which was not seen in the ATN kidneys, gave the
sonographer an advantage over the reviewer who was limited to
the still images. With the triangular shape of the pyramid, the
moving echoes became crowded near the papillary tip imparting
an echogenic gradient that increased in brightness from the
corticomeduilary junction towards the tip of the papilla (Fig.
4C). The cortex, also enhanced by PFOB, was more echogenic
than the corticomedullary junction. The latter appeared as an
arc of lesser echogenicity (Fig. 4D). The kidney with ATN
developed an echogenic gradient across the medulla; however,
the gradient was in the reverse direction. In the ATN kidney,
the medulla was less echogenic than the cortex even at the high
dose, the corticomedullary junction was not apparent, and the
medullary echogenicity decreased towards the papillary tip
(Fig. 5).
Histogram analysis failed to detect any significant change in
the corticomedullary contrast for either the ATN (—11.1 9.2)
or the normal (21.1 9.2) kidney after 5 mllkg saline was
infused (Fig. 6). On the other hand, the contrast was signifi-
cantly altered in both the normal and the ATN kidney after
PFOB administration (Fig. 6). Corticomedullary contrast of the
normal kidney decreased after 1 mi/kg PFOB by 27.6 8.3% (P
<0.05) while that of the ATN kidney was unchanged (+0.47
10.7%). The ATN kidney required 2.5 mjlkg of PFOB to cause
a significant decrease of 18.9% 7.6. While the corticomedui-
lary contrast after 5 mllkg decreased by 116.9 10.3% for the
normal kidney (P < 0.01; medulla became brighter than cortex)
it only decreased by 39.5 7.8% (P <0.01) for the ATN kidney
(medulla remained darker than cortex).
The difference in corticomedullary contrast between the
normal and ATN kidneys was not significantly different after 1
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Fig. 6. Effect of saline and PFOB on quantitative measure of corti-
comedullary contrast shown as mean percent change (±sEM) relative to
post-A TN and pre-contrast image. * P < 0.05 and ** P < 0.01
significance when comparing corticomedullary contrast at each dose to
contrast obtained pre-infusion; + + P < 0.01 significance when
comparing corticomedullary contrast of normal to contrast of ATN
kidney at each dose. Symbols are: (-) normal (saline); (-e—) ATN
(saline); (-U-) normal PFOB; (-) ATN (PFOB).
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Fig. 7. Effect of furosemide on corticomedullary echo genicity in nor-
mal kidneys. A. Image obtained after 2.5 mi/kg PFOB. Note the
increase in medullary echogenicity most pronounced near the tip of the
papilla (arrow). Medulla was hypoechoic pre-PFOB (not shown). B.
One minute after furosemide the degree of medullary enhancement is
markedly decreased relative to cortex.
mi/kg PFOB. The contrast became significant at the higher
doses (P < 0.01).
Effect of furosemide on corticomedullary contrast
Medullary enhancement was observed in both the right and
left normal kidneys of the two rabbits imaged after 2.5 mI/kg of
PFOB (Fig. 7A). Within two minutes after 50 mg of i.v.
furosemide, medullary enhancement began to wash out from
the corticomedullary junction towards the papillary tip (Fig. 7).
Although medullary enhancement decreased after furosemide,
the degree of medullary darkening relative to cortex was not as
profound as in the ATN kidneys particularly near the papillary
tip. Moderate recovery of medullary echogenicity occurred
within two minutes after peak furosemide effect, but the degree
of echogenicity did not return to the level observed before
furosemide (not shown).
Discussion
Acute tubular necrosis (ATN) is defined as an abrupt deteri-
oration of kidney function after an ischemic or nephrotoxic
insult and is frequently seen in hospitalized patients [11]. The
most common cause of ATN is renal ischemia, which can occur
with renal transplantation, severe prolonged hypotension or
shock, and other conditions that compromise blood flow to the
kidney [13]. ATN can cause varied histologic changes usually
including varying degrees of tubular necrosis with normal
glomeruli and normal intrarenal blood vessels 1113]. Several
investigators have used sonography to evaluate parenchymal
changes in ATN, Whereas some have described an increase in
renal size and decreased echogenicity of central parenchymal
echoes [5, 14, 151, others could find no change in human or
canine models attributable to ATN [2—5, 16].
In prospect, without the knowledge of which kidney was
impaired and prior to contrast administration, skilled observers
were unable to detect an appreciable change caused by ATN.
When told which kidney had ATN, they noted a decrease in
medullary echogenicity relative to the pre-ATN image and the
normal contralateral kidney in less than 50% of rabbits (8 of 17).
The discrepancy between the prospective and retrospective
observations is due to the significant variability in the sono-
graphic appearance of kidneys. Quantitatively, ATN caused a
loss in medullary echoes increasing contrast in the ipsilateral
kidney by 12,3 5.8% (P < 0.05), and caused an increase in
medullary echoes in the normal contralateral kidney decreasing
contrast by 32.9 9.9% (P <0.01). The exact mechanism for
this observation is not clear, but could be due to an increase in
cortical echogenicity induced by ATN or to a loss in medullary
echogenicity. It is intriguing to speculate that blood constitu-
ents like PFOB, are concentrated by the osmotic gradient and
impart to the medulla of the normal kidney an echogenic
character that is erased when the osmotic gradient is destroyed
by ATN.
PFOB emulsion (ImagentR BP, Alliance), a radiopaque con-
trast agent, when given intravenously remains in the vascular
space (half-life in hours) until phagocytosed by the reticuloen-
dothelial system or evaporated via the lungs, thus serving as a
blood pool imaging agent for computed tomography (CT) [6].
Since PFOB is also an effective ultrasound contrast agent, it
enhances the Doppler signal from vessels [8, 9] and enhances
the echogenicity of perfused tissues to a degree commensurate
with their blood content [9, 10]. Using CT, we demonstrated in
a canine model that PFOB increased the brightness of the renal
medulla more than that of cortex because of the osmotic
gradient across the medulla [7]. We also showed that the
medulla lost this enhancement promptly following furosemide
administration, which is known to destroy the concentrating
ability of the kidney [71. It was hypothesized that since PFOB is
limited to the vascular space, PFOB, like other plasma constit-
uents, became more concentrated in the vasa rectae as it
traveled down the osmotic gradient towards the papilla.
With PFOB as a marker, the effect of the osmotic gradient on
medullary echogenicity became obvious and allowed observers
to distinguish normal from ATN kidneys in all rabbits prospec-
tively after 2.5 mI/kg was administered. In eight of 10 rabbits,
this was accomplished after the smaller PFOB dose of 1 mi/kg.
The medullary echoes observed in normal kidneys on real-time
sonography after PFOB, which traveled from the corticomed-
ullary junction to the tip of the papilla and back again, suggests
that these echoes were caused by PFOB as it traveled through
the vasa rectae. Because PFOB produced a visible gradient of
echoes across the medulla of normal kidneys increasing
towards the papillary tip that was reversed in kidneys with ATN
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and decreased by furosemide suggests that the osmotic gradient
is necessary for PFOB to produce this effect. In none of the
rabbits given PFOB did the degree of medullary echogenicity in
the ATN kidney even approach that of the cortex. Indeed, after
5 mllkg of PFOB which caused a reversal in the corticomedul-
lary contrast in normal kidneys (medulla became brighter than
cortex), contrast decreased by only 39.6% in the ATN kidneys.
This observation is not surprising since PFOB enhances the
echogenicity of perfused tissues to degree commensurate with
their blood content [10], cortex has more blood than medulla
[7], and the osmotic gradient which increases the concentration
of PFOB is preserved in the normal kidney and destroyed in the
ATN kidney.
In this study we have assumed that a major effect of ATN is
the elimination of the osmotic gradient. While it is possible that
some of the observed differences between the normal and ATN
kidneys may have been due to some other mechanism, we
believe this is unlikely. Based on the results of our previous CT
experiment [7] and the current study, it appears that PFOB is a
marker for the osmotic gradient on both CT and sonography.
Moreover, the elimination of the medullary enhancement pro-
duced by PFOB on sonograms of ATN kidneys and after
furosemide is consistent with destruction of the medullary
osmotic gradient. We believe that the discrepancy in the degree
of darkening of the medulla of kidneys with ATN and those
imaged after furosemide is due to the fact that ATN produces a
more complete and lasting destruction of the osmotic gradient.
The evidence from this study indicates that PFOB-enhanced
sonography provides not only anatomic information, but also
important physiologic information, heretofore unattainable.
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